Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 381

1.

Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.

Zheng K, Chen M, Xiang Y, Ma K, Jin F, Wang X, Wang X, Wang S, Wang Y.

Biochem Biophys Res Commun. 2014 Apr 18;446(4):990-6. doi: 10.1016/j.bbrc.2014.03.050. Epub 2014 Mar 19.

PMID:
24657267
2.

Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.

Schneider SM, Pritchard SM, Wudiri GA, Trammell CE, Nicola AV.

MBio. 2019 May 14;10(3). pii: e00732-19. doi: 10.1128/mBio.00732-19.

3.

A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.

Tiwari V, Shukla SY, Shukla D.

Antiviral Res. 2009 Oct;84(1):67-75. doi: 10.1016/j.antiviral.2009.07.014. Epub 2009 Aug 7.

4.
5.

Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.

Schuhmacher A, Reichling J, Schnitzler P.

Phytomedicine. 2003;10(6-7):504-10.

PMID:
13678235
6.

Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.

Hubbard S, Choudhary S, Maus E, Shukla D, Swenson S, Markland FS Jr, Tiwari V.

Antivir Ther. 2012;17(7):1319-26. doi: 10.3851/IMP2291. Epub 2012 Aug 8.

PMID:
22875654
7.

Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.

Gescher K, Kühn J, Lorentzen E, Hafezi W, Derksen A, Deters A, Hensel A.

J Ethnopharmacol. 2011 Mar 24;134(2):468-74. doi: 10.1016/j.jep.2010.12.038. Epub 2011 Jan 4.

PMID:
21211557
8.

Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.

Duan J, Liuzzi M, Paris W, Lambert M, Lawetz C, Moss N, Jaramillo J, Gauthier J, Déziel R, Cordingley MG.

Antimicrob Agents Chemother. 1998 Jul;42(7):1629-35.

9.

Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.

Ziyaeyan M, Alborzi A, Japoni A, Kadivar M, Davarpanah MA, Pourabbas B, Abassian A.

Int J Dermatol. 2007 Dec;46(12):1263-6. doi: 10.1111/j.1365-4632.2007.03449.x.

PMID:
18173520
10.

Anti-HSV activity of digitoxin and its possible mechanisms.

Su CT, Hsu JT, Hsieh HP, Lin PH, Chen TC, Kao CL, Lee CN, Chang SY.

Antiviral Res. 2008 Jul;79(1):62-70. doi: 10.1016/j.antiviral.2008.01.156. Epub 2008 Feb 21.

PMID:
18353452
11.

2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Strand M, Islam K, Edlund K, Oberg CT, Allard A, Bergström T, Mei YF, Elofsson M, Wadell G.

Antimicrob Agents Chemother. 2012 Nov;56(11):5735-43. doi: 10.1128/AAC.01072-12. Epub 2012 Aug 20.

12.

Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice.

Chuanasa T, Phromjai J, Lipipun V, Likhitwitayawuid K, Suzuki M, Pramyothin P, Hattori M, Shiraki K.

Antiviral Res. 2008 Oct;80(1):62-70. doi: 10.1016/j.antiviral.2008.05.002. Epub 2008 Jun 2.

PMID:
18565600
13.

Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.

Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura M, Shiraki K.

J Med Virol. 2004 Jan;72(1):112-20.

PMID:
14635018
14.

Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.

Antoine TE, Shukla D.

Antivir Ther. 2014;19(1):15-29. doi: 10.3851/IMP2661. Epub 2013 Jun 28.

PMID:
23813409
15.

Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.

Tiwari V, Liu J, Valyi-Nagy T, Shukla D.

J Biol Chem. 2011 Jul 15;286(28):25406-15. doi: 10.1074/jbc.M110.201103. Epub 2011 May 19.

16.

Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.

Gong Y, Matthews B, Cheung D, Tam T, Gadawski I, Leung D, Holan G, Raff J, Sacks S.

Antiviral Res. 2002 Aug;55(2):319-29.

PMID:
12103432
17.

Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.

Huang WY, Su YH, Yao HW, Ling P, Tung YY, Chen SH, Wang X, Chen SH.

J Gen Virol. 2010 Mar;91(Pt 3):591-8. doi: 10.1099/vir.0.016964-0. Epub 2009 Nov 11.

PMID:
19906941
18.

Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.

Shiota T, Lixin W, Takayama-Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M.

Antiviral Res. 2011 Aug;91(2):142-9. doi: 10.1016/j.antiviral.2011.05.015. Epub 2011 Jun 2.

PMID:
21669227
19.

Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.

Wang Y, Wang Q, Zhu Q, Zhou R, Liu J, Peng T.

J Clin Virol. 2011 Oct;52(2):107-12. doi: 10.1016/j.jcv.2011.06.009. Epub 2011 Jul 20.

PMID:
21778105
20.

In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.

Sasaki K, Hayashi K, Matsuya Y, Sugimoto K, Lee JB, Kurosaki F, Hayashi T.

J Nat Med. 2016 Apr;70(2):217-24. doi: 10.1007/s11418-016-0964-6. Epub 2016 Jan 13.

PMID:
26763002

Supplemental Content

Support Center